New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

The Report

Verified funding, headquarters, and leadership news from the world's most innovative businesses

198 reports and counting

Updated daily with latest market intelligence
Fundraising
MapLight Therapeutics

MapLight Therapeutics Raises $372.5M in Series D

MapLight Therapeutics, a HealthTech company based in San Francisco, CA, has raised $372.5M in Series D at a $2B valuation led by Andreessen Horowitz Bio, 8VC.

Fundraising News Team
Aug 1, 2025
0 min read
HealthTech
MapLight Therapeutics

MapLight Therapeutics raises $372.5M Series D

MapLight Therapeutics raises $372.5M in Series D. Biopharma company developing medicines for brain disorders using novel drug discovery platform...

Editorial Team
Sep 29, 2025
0 min read•$372.5M
Fundraising
Maplight

Maplight Raises $160M in Series C

Maplight, a AI/ML company based in San Francisco, CA, has raised $160M in Series C from multiple investors.

Fundraising News Team
Aug 2, 2025
0 min read
AI/ML
Maplight

Maplight raises $160M Series C

Maplight raises $160M in Series C. AI mapping and geospatial intelligence platform...

Editorial Team
Aug 2, 2025
0 min read•$160M
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read•$205M
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.